Intellia Therapeutics Inc (NTLA)

NASDAQ · Biotechnology

11.63
-0.46 (-3.80%)
Updated Aug 18, 4:42 PM ET
AI Rating
Hold
Overall Score
49
Trend
28
Momentum
66
Risk
58

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

Intellia Therapeutics Inc is trading at $11.63, down 3.80% on the session. The 50 day average sits at $13.38 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 47.3, which reads as neutral, and MACD is bullish crossover. Volume is below average.

The nearest support is around $11.81 with resistance near $14.30, so that band frames the current range. Average daily movement is roughly $0.69, or about 5.9% of the share price, which is what any stop placement has to allow for. The overall health score of 49 out of 100 combines a trend score of 28, momentum of 66 and a risk score of 58.

Technical indicators

RSI (14)
47.3
neutral
MACD
-0.390
bullish crossover
SMA 20
11.28
SMA 50
13.38
SMA 200
--
unknown
ATR (14)
0.69
avg daily range
Support
11.81
Resistance
14.30
Volume vs 20d
0.67x
below average
Volatility
47.6%
annualised
1 month
+0.42%
3 months
-9.02%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.